Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Professional Survey Report 2019

The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Transient Receptor Potential Cation Channel Subfamily V Member 1 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transient Receptor Potential Cation Channel Subfamily V Member 1 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Transient Receptor Potential Cation Channel Subfamily V Member 1 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Transient Receptor Potential Cation Channel Subfamily V Member 1 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen Inc
Amorepacific Corp
BCN Peptides SA
Centrexion Therapeutics Corp
Daewoong Pharmaceutical Co Ltd
DoNatur GmbH
Flex Pharma Inc
Grunenthal GmbH
Kyowa Hakko Kirin Co Ltd
Medifron DBT Co Ltd
Neurim Pharmaceuticals Ltd
Pila Pharma AB
Sylentis SAU
Toray Industries Inc
Vitality Biopharma Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
CMX-020
CA-016
DD-04107
Others

Segment by Application
Ophthalmology
Immunology
Muscle Spasm
Pruritus
Abdominal Pain
Others